Authors' reply

Statistics in Medicine

Volumn 27, Issue 19, 2008, Pages 3912-3914

  Shuster, Jonathan J ^a   Jones, Lynn S ^b   Salmon, Daniel A ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Midwest Clinical Research   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE; PLACEBO; ROSIGLITAZONE;

CLINICAL TRIAL; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EFFECT SIZE; EVIDENCE BASED MEDICINE; HEART DEATH; HEART INFARCTION; HUMAN; LETTER; MATHEMATICAL ANALYSIS; MEDICAL RESEARCH; METHODOLOGY; NOSE CONGESTION; OUTCOME ASSESSMENT; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; TREATMENT OUTCOME; VARIANCE;

EID: 50449110888     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3347     Document Type: Letter

References (3)

1. Carpenter J, Rucker G, Schwarzer G. Comments on 'Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death' by J. J. Shuster, L. S. Jones and D. A. Salmon. Statistics in Medicine 2008; DOI: 10.1002/ sim.3173.
2. Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death. Statistics in Medicine 2007; 26:4375-4385.
3. Kollar C, Schneider H, Waksman J, Krusinska E. Meta-analysis of the efficacy of a single dose of phenylephrine 10mg compared with placebo in adults with acute nasal congestion due to the common cold. Clinical Therapeutics 2007; 29(6):1057-1070.